Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Eton Pharmaceuticals, Inc. (ETON) had Return on Investments of 3.09% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$21.28M |
|
$1.48M |
|
$8.18M |
|
$13.10M |
|
$18.82M |
|
$2.46M |
|
$-1.05M |
|
$1.41M |
|
$1.41M |
|
$1.48M |
|
$1.48M |
|
$1.48M |
|
$1.48M |
|
$2.46M |
|
$3.66M |
|
26.91M |
|
26.91M |
|
$0.06 |
|
$0.06 |
|
| Balance Sheet Financials | |
$60.58M |
|
$0.33M |
|
$31.53M |
|
$92.11M |
|
$38.49M |
|
$21.77M |
|
$27.47M |
|
$65.96M |
|
$26.15M |
|
$-4.72M |
|
$26.15M |
|
27.05M |
|
| Cash Flow Statement Financials | |
$10.52M |
|
$-0.33M |
|
$0.81M |
|
$14.94M |
|
$25.94M |
|
$11.01M |
|
$5.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.57 |
|
-- |
|
-- |
|
0.45 |
|
1.17 |
|
61.56% |
|
11.58% |
|
11.58% |
|
-- |
|
6.64% |
|
6.97% |
|
$10.19M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.53 |
|
1.81 |
|
49.72 |
|
5.67% |
|
-31.39% |
|
1.61% |
|
|
Return on Investments |
3.09% |
$0.97 |
|
$0.38 |
|
$0.39 |
|